Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patent Expiration

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was first introduced by Teva Womens Health Inc in its drug Adderall 20 on Feb 13, 1996. Other drugs containing Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate are Adderall Xr 5, Adderall 30, Adderall Xr 25, Adderall Xr 10, Adderall Xr 30, Adderall 5, Adderall 15, Adderall 7.5, Adderall Xr 15, Adderall Xr 20, Mydayis, Adderall 12.5, Adderall 10. 31 different companies have introduced drugs containing Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate.


Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Patents

Given below is the list of patents protecting Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Mydayis US8846100 Controlled dose drug delivery system Aug 24, 2029 Takeda Pharms Usa
Mydayis US9173857 Controlled dose drug delivery system May 12, 2026 Takeda Pharms Usa
Mydayis US6913768 Sustained release delivery of amphetamine salts May 24, 2023

(Expired)

Takeda Pharms Usa
Adderall 10 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 12.5 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 15 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 20 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 30 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 5 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 7.5 US6384020

(Pediatric)

Rapid immediate release oral dosage form Jan 06, 2021

(Expired)

Teva Womens
Adderall 10 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 12.5 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 15 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 20 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 30 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 5 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall 7.5 US6384020 Rapid immediate release oral dosage form Jul 06, 2020

(Expired)

Teva Womens
Adderall Xr 10 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 10 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 10 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 10 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 15 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 15 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 15 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 15 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 20 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 20 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 20 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 20 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 25 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 25 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 25 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 25 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 30 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 30 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 30 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 30 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 5 US6322819

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 5 US6605300

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 5 USRE41148

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 5 USRE42096

(Pediatric)

Oral pulsed dose drug delivery system Apr 21, 2019

(Expired)

Takeda Pharms Usa
Adderall Xr 10 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 10 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 10 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 10 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 15 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 15 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 15 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 15 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 20 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 20 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 20 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 20 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 25 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 25 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 25 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 25 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 30 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 30 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 30 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 30 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 5 US6322819 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 5 US6605300 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 5 USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Adderall Xr 5 USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Mydayis USRE41148 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa
Mydayis USRE42096 Oral pulsed dose drug delivery system Oct 21, 2018

(Expired)

Takeda Pharms Usa



Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Generic API Manufacturers

Several generic applications have been filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. The first generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate was by Barr Laboratories Inc and was approved on Feb 11, 2002. And the latest generic version is by Alkem Laboratories Ltd and was approved on Oct 6, 2023.

Given below is the list of companies who have filed for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Discontinued ORAL N/A Nov 22, 2021
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Discontinued ORAL N/A Nov 22, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Discontinued ORAL N/A Nov 22, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Discontinued ORAL N/A Nov 22, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Discontinued ORAL N/A Nov 22, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Discontinued ORAL N/A Nov 22, 2021
5MG; 5MG; 5MG; 5MG

tablet Discontinued ORAL N/A Nov 22, 2021





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Feb 5, 2016
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Feb 5, 2016
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Feb 5, 2016
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Feb 5, 2016
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Jun 22, 2012
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Feb 5, 2016
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Feb 5, 2016
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Feb 5, 2016


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Oct 6, 2023
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Oct 6, 2023
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Oct 6, 2023
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Oct 6, 2023
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Oct 6, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Oct 6, 2023
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Oct 6, 2023





4. ALVOGEN

Alvogen Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Jul 28, 2017
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Jul 28, 2017
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Jul 28, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Jul 28, 2017
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Jul 28, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Jul 28, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Jul 28, 2017


Manufacturing Plant Locations
New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country City Firm Name
United States
Morristown Alvogen, Inc





5. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Jan 22, 2019





6. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Apr 22, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Apr 22, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Sep 29, 2021





7. AUROLIFE PHARMA LLC

Aurolife Pharma Llc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Aurolife Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Nov 27, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Nov 27, 2013
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A Jun 24, 2020


Manufacturing Plant Locations
New

Aurolife Pharma Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Aurolife Pharma Llc as present at those locations.

Country City Firm Name
United States
Durham Aurolife Pharma LLC





8. BARR

Barr Laboratories Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

(reference standard)

tablet Prescription ORAL AB Feb 11, 2002
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Feb 11, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Feb 11, 2002
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Feb 11, 2002
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Mar 19, 2003
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Mar 19, 2003
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Mar 19, 2003


Manufacturing Plant Locations
New

Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.

Country City Firm Name
Mexico
Aldama Barra La Coma, S. De R.L
Singapore
Singapore Barramundi Asia Pte Ltd
United States
Hereford Barrett and Crofoot Feedyard, West
Arecibo Barreto Dairy, Inc.
Buffalo Barrel and Brine Inc
Englewood Barrett E. Cowan, MD
Forest Barr Laboratories Inc.
Paso Robles Barreto Cellars
Dillon Barretts Minerals Inc
Davie Barrier Technologies LLC
Commerce Barreras Meat Co
Harrison Barrington Chemical Corporation
Live Oak Barrington Dairy Farm
Newton Barrett Technology, LLC
Hereford Barrett and Crofoot, LLP
Lake Barrington Barrington Ventures, Ltd
Barrett Barrett Farm Supply, Inc.
Lee Barrington Coffee Roasting Company, Inc.
Franklin Barrett Distribution Centers, Inc.
Randolph Barrett Farm
Greenwood Barr Enterprises, Inc.
Swartz Creek Barrett Donut Mixes, Inc..
Brainerd Barrett Ag Service, Inc.
Memphis Barrett Distribution Centers
Madison Barriques Holding Company, LLC
Somerset Barrett Distribution Centers Inc
Curtis Bay Barrett Distribution Center
Machipongo Barrier Island Seafood
Belvidere Barred Woods, LLC
Montezuma Barrington Dairies
Philippines
Bulacan Barrio Fiesta Manufacturing Corporation





9. BARR LABS INC

Barr Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A Feb 12, 2013





10. CEDIPROF INC

Cediprof Inc has filed for 5 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Cediprof Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Discontinued ORAL N/A Jul 5, 2022
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Discontinued ORAL N/A Jul 5, 2022
5MG; 5MG; 5MG; 5MG

tablet Discontinued ORAL N/A Jul 5, 2022
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Discontinued ORAL N/A Jul 5, 2022
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Discontinued ORAL N/A Jul 5, 2022





11. ELITE LABS INC

Elite Laboratories Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Elite Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Dec 7, 2018
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Dec 7, 2018
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Dec 11, 2019





12. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A May 31, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A May 31, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A May 31, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A May 31, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A May 31, 2019
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A May 31, 2019





13. EPIC PHARMA LLC

Epic Pharma Llc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Jun 19, 2002
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Jun 19, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Jun 19, 2002
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Jun 19, 2002
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Nov 3, 2014
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Nov 3, 2014
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Nov 3, 2014





14. GRANULES

Granules Pharmaceuticals Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Dec 28, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Dec 28, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Jan 23, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Manassas Granules Consumer Health Inc.
Chantilly Granules Pharmaceuticals Inc.
India
Sangareddy District Granules India Limited
Visakhapatnam Granules India Limited
Secunderabad Granules India Limited
Parawada Mandal Granules India Limited
Medchal-Malkhajgiri District Granules India Limited





15. IMPAX LABS

Impax Laboratories Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Feb 16, 2016





16. LANNETT CO INC

Lannett Co Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Jul 8, 2022
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Jul 8, 2022
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Jul 8, 2022
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Jul 8, 2022
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 Nov 26, 2021
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Jul 8, 2022
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Jul 8, 2022
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Jul 8, 2022





17. NESHER PHARMS

Nesher Pharmaceuticals Usa Llc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nesher Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A Jul 17, 2019





18. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Discontinued ORAL N/A Nov 10, 2015
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Discontinued ORAL N/A Nov 10, 2015
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Discontinued ORAL N/A Nov 10, 2015
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Discontinued ORAL N/A Nov 10, 2015
5MG; 5MG; 5MG; 5MG

tablet Discontinued ORAL N/A Nov 10, 2015
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Discontinued ORAL N/A Nov 10, 2015
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Discontinued ORAL N/A Nov 10, 2015





19. NUVO PHARM

Nuvo Pharmaceutical Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Nuvo Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Dec 28, 2017
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Dec 28, 2017
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Dec 28, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Dec 28, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Dec 28, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Dec 28, 2017
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Dec 28, 2017


Manufacturing Plant Locations
New

Nuvo Pharm's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Nuvo Pharm as present at those locations.

Country City Firm Name
Canada
Varennes Nuvo Pharmaceuticals Inc.





20. ORYZA

Oryza Pharmaceuticals Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Oryza.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Apr 3, 2020
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Apr 3, 2020
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Apr 3, 2020
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Apr 3, 2020
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Apr 3, 2020
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Apr 3, 2020


Manufacturing Plant Locations
New

Oryza's manufacturing plants are situated in 1 country - Japan. Given below are the details of these plant locations as well as the firm names of Oryza as present at those locations.

Country City Firm Name
Japan
Ichinomiya Oryza Oil & Fat Chemical Co., Ltd.





21. RHODES PHARMS

Rhodes Pharmaceuticals Lp has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Rhodes Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Jan 13, 2021
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Jan 13, 2021
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Jan 13, 2021
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Jan 13, 2021
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB1 May 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Jan 13, 2021
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Jan 13, 2021
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Jan 13, 2021





22. SANDOZ

Sandoz Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Jun 14, 2002
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Jun 14, 2002
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Jun 14, 2002
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Sep 27, 2002


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





23. SPECGX LLC

Specgx Llc has filed for 10 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Specgx Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.125MG; 3.125MG; 3.125MG; 3.125MG

capsule, extended release Prescription ORAL AB2 Aug 31, 2023
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Prescription ORAL AB1 Apr 22, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Oct 7, 2003
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Prescription ORAL AB1 Apr 22, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Prescription ORAL AB1 Apr 22, 2019
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Prescription ORAL AB1 Apr 22, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Prescription ORAL AB1 Apr 22, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB2 Aug 31, 2023
9.375MG; 9.375MG; 9.375MG; 9.375MG

capsule, extended release Prescription ORAL AB2 Aug 31, 2023
12.5MG; 12.5MG; 12.5MG; 12.5MG

capsule, extended release Prescription ORAL AB2 Aug 31, 2023


Manufacturing Plant Locations
New

Specgx Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Specgx Llc as present at those locations.

Country City Firm Name
United States
Greenville SpecGx LLC
Saint Louis SpecGx LLC
Raleigh SpecGx LLC





24. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB2 Sep 27, 2023
3.125MG; 3.125MG; 3.125MG; 3.125MG

capsule, extended release Prescription ORAL AB2 Sep 27, 2023
12.5MG; 12.5MG; 12.5MG; 12.5MG

capsule, extended release Prescription ORAL AB2 Sep 27, 2023
9.375MG; 9.375MG; 9.375MG; 9.375MG

capsule, extended release Prescription ORAL AB2 Sep 27, 2023





25. SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries Inc has filed for 8 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A May 17, 2019
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A May 17, 2019
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A May 17, 2019
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Sep 9, 2003
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A May 17, 2019
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Sep 9, 2003
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A May 17, 2019
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A May 17, 2019





26. TEVA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013
5MG; 5MG; 5MG; 5MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013
1.25MG; 1.25MG; 1.25MG; 1.25MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013
3.75MG; 3.75MG; 3.75MG; 3.75MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013
2.5MG; 2.5MG; 2.5MG; 2.5MG

capsule, extended release Discontinued ORAL N/A Apr 29, 2013


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Fort Dodge TEVA Animal Health Inc
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Stouffville Teva Canada Limited
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





27. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Discontinued ORAL N/A Sep 30, 2003
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Discontinued ORAL N/A Sep 30, 2003
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Discontinued ORAL N/A Sep 30, 2003
5MG; 5MG; 5MG; 5MG

tablet Discontinued ORAL N/A Sep 30, 2003





28. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3.125MG; 3.125MG; 3.125MG; 3.125MG

capsule, extended release Prescription ORAL AB2 Jan 31, 2022
12.5MG; 12.5MG; 12.5MG; 12.5MG

capsule, extended release Prescription ORAL AB2 Jan 31, 2022
9.375MG; 9.375MG; 9.375MG; 9.375MG

capsule, extended release Prescription ORAL AB2 Jan 31, 2022
6.25MG; 6.25MG; 6.25MG; 6.25MG

capsule, extended release Prescription ORAL AB2 Jan 31, 2022





29. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. All of these versions come by the name DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG; 2.5MG; 2.5MG; 2.5MG

tablet Prescription ORAL AB Oct 31, 2017
3.125MG; 3.125MG; 3.125MG; 3.125MG

tablet Prescription ORAL AB Oct 31, 2017
3.75MG; 3.75MG; 3.75MG; 3.75MG

tablet Prescription ORAL AB Oct 31, 2017
5MG; 5MG; 5MG; 5MG

tablet Prescription ORAL AB Oct 31, 2017
7.5MG; 7.5MG; 7.5MG; 7.5MG

tablet Prescription ORAL AB Oct 31, 2017
1.25MG; 1.25MG; 1.25MG; 1.25MG

tablet Prescription ORAL AB Oct 31, 2017
1.875MG; 1.875MG; 1.875MG; 1.875MG

tablet Prescription ORAL AB Oct 31, 2017